Program Announcement (4 pages)
The Alzheimer’s Association, Alzheimer’s Research UK and the Weston Brain Institute announce a collaborative Request for Applications (RFA). The "MEchanisms of cellular death in NeuroDegeneration" (MEND) funding program’s overall goal is to discover and understand the mechanisms and pathophysiological processes by which brain cell loss is medicated in disease and thereby seek insights and potential targets for therapeutic interventions that would sustain healthy brain function.
Application procedures and key dates are now available, visit alz.org/MEND for information regarding eligibility and requirements.
All Investigators Program:
January 2015 - August 2015
2015 Complete All Investigators Program Announcement (71 pages)
Investigator-Initiated Research Grant – Request for Applications
a. Biological Underpinnings of Genetic Risk Factors in Alzheimer’s disease (BGF) – This aims to promote further understanding of the underlying biological mechanism of ‘genetic risk’ factors, identified by Genome Wide Association Studies (GWAS), rare-variant studies, DNA sequence-based approaches, or other genomic approaches, associated with Alzheimer’s disease (AD) and related dementia.
b. Discovery-Validation of Therapeutic Targets for Developing Novel Interventions of Alzheimer’s disease (DVT) - This aims to stimulate the discovery-validation of a broad spectrum of potential therapeutic targets and/or agents that could be tested in human subjects as putative disease modifying interventions for Alzheimer’s disease.
c. Non-Pharmacological Strategies to Ameliorate Symptoms of Alzheimer’s Disease and Related Dementia (NPSASA) – This aims at the identification, validation and investigation of non-pharmacological approaches to improve the care of older adults with Alzheimer’s and related dementia.
d. Role of Vascular Metabolic Factors in Pathogenesis of Alzheimer’s disease and Related Dementia (VMF) – This aims to broaden the conceptual models and areas of explorations regarding potential contributing factors to the pathogenesis of neurodegeneration/ Alzheimer’s disease/ dementia.
e. Understanding the Development and Devising Treatments for Alzheimer’s Disease in Individuals with Down Syndrome (DS/AD) - The Alzheimer’s Association, in collaboration with the Linda Crnic Institute for Down Syndrome and the Global Down Syndrome Foundation, is launching a second initiative to understand the development of Alzheimer’s disease (AD) in individuals with Down syndrome (DS).
New Investigator Research Grant (NIRG) (3 pages)
Funds the next generation of promising scientists who have earned their doctoral degrees within the last 10 years
New Investigator Research Grant to Promote Diversity (NIRGD)
Funds new investigators from diverse backgrounds with intent to support early career development that will lay groundwork for future research grants.
Mentored New Investigator Research Grant to Promote Diversity (MNIRGD) (4 pages)
Funds mentored research conducted by underrepresented researchers.
The Zenith Fellows Award Program (ZENITH) (3 pages)
The objective of this competition is to provide major support for investigators who have: Contributed significantly to the field of Alzheimer’s disease research, Made significant contributions to other areas of science and are now beginning to focus more directly on problems related to Alzheimer‘s disease, and are likely to make substantial contributions in the future.
Everyday Technologies for Alzheimer Care (ETAC) (3 pages)
The Alzheimer’s Association seeks proposals focused on personalized diagnostics, preventive tools and interventions for adults coping with the spectrum of cognitive aging and neurodegenerative disease, particularly Alzheimer’s disease.
(CLOSED) Part the Cloud - Translational Research Funding for
May - October 2014
Part the Cloud - Translational Research Funding for Alzheimer’s Disease (3 pages)
(CLOSED) Biomarkers Across Neurodegenerative Diseases - BAND:
February – August 2014
Program Announcement (4 pages)
How to apply for a grant
See the Application Process and Timeline page for information about the grants application process, review procedures and reporting requirements.
For more information: Contact email@example.com or call 312.335.5747.
Next: Process and Timeline »